2010, Drugs and the pharmaceutical sciences, ISBN 0849377846, Volume 204, x, 264
Book
2001, ISBN 3527302018, xi, 434
Book
1988, ISBN 9780824778170, 2 v.
Book
2005, 8th ed., ISBN 0781746124, xi, 738
Book
1996, 2nd ed., rev. and expanded., ISBN 0824793870, 3 v.
Book
1984, ISBN 0824770846, 2 v.
Book
1989, 2nd ed., rev. and expanded. --, ISBN 9780824783006, 3 v.
Book
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2017, Volume 76, Issue 1, pp. 17 - 28
Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general...
Journal Article | FACTOR-ALPHA THERAPY | B-CELL LYMPHOMA | MODIFYING ANTIRHEUMATIC DRUGS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACUTE MYOCARDIAL-INFARCTION | NECROSIS-FACTOR INHIBITORS | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | ACUTE CORONARY SYNDROME | DOSE GLUCOCORTICOID THERAPY | Cardiovascular Diseases - etiology | Life Style | Risk Assessment | Risk Management - methods | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Spondylitis, Ankylosing - drug therapy | Rheumatology | Spondylitis, Ankylosing - complications | Adrenal Cortex Hormones - therapeutic use | Arthritis, Rheumatoid - complications | Directive Counseling | Arthritis, Psoriatic - complications | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis, Rheumatoid - drug therapy | Arthritis, Psoriatic - drug therapy | Antirheumatic Agents - therapeutic use | Physician's Role | Epidemiologists | Complications and side effects | Care and treatment | Rheumatoid arthritis | Practice | Joint diseases | Cardiovascular diseases | Risk factors | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | General Practice | Allmänmedicin | Klinisk medicin
Journal Article | FACTOR-ALPHA THERAPY | B-CELL LYMPHOMA | MODIFYING ANTIRHEUMATIC DRUGS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACUTE MYOCARDIAL-INFARCTION | NECROSIS-FACTOR INHIBITORS | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | ACUTE CORONARY SYNDROME | DOSE GLUCOCORTICOID THERAPY | Cardiovascular Diseases - etiology | Life Style | Risk Assessment | Risk Management - methods | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Spondylitis, Ankylosing - drug therapy | Rheumatology | Spondylitis, Ankylosing - complications | Adrenal Cortex Hormones - therapeutic use | Arthritis, Rheumatoid - complications | Directive Counseling | Arthritis, Psoriatic - complications | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis, Rheumatoid - drug therapy | Arthritis, Psoriatic - drug therapy | Antirheumatic Agents - therapeutic use | Physician's Role | Epidemiologists | Complications and side effects | Care and treatment | Rheumatoid arthritis | Practice | Joint diseases | Cardiovascular diseases | Risk factors | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | General Practice | Allmänmedicin | Klinisk medicin
Journal Article
1974, 273
Book
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 01/2012, Volume 101, Issue 1, pp. 322 - 332
Electrospinning (ES) and extrusion of a poorly water-soluble active pharmaceutical ingredient were used to improve its dissolution, which is a major challenge...
improved dissolution rate | Raman microscopy | electrospinning | solid solution | solid dispersion | polymeric drug delivery | oral drug delivery | extrusion | nanotechnology | nanofibers | Electrospinning | Extrusion | Improved dissolution rate | Solid dispersion | Oral drug delivery | Polymeric drug delivery | Nanofibers | Solid solution | Nanotechnology | DISPERSIONS | CHEMISTRY, MEDICINAL | BEHAVIOR | AMORPHOUS STATE | PHARMACEUTICAL SYSTEMS | CHEMISTRY, MULTIDISCIPLINARY | SOLUBILITY | SPIRONOLACTONE | WATER-SOLUBLE DRUGS | ORAL BIOAVAILABILITY | PHARMACOLOGY & PHARMACY | MELT EXTRUSION | Chemistry, Pharmaceutical - methods | Calorimetry, Differential Scanning - methods | Solubility | Spironolactone - chemistry | Polyethylene Glycols - chemistry | Technology, Pharmaceutical - methods | Spectrum Analysis, Raman - methods | Drug Carriers - chemistry | Microscopy, Electron, Scanning - methods | Ethanol - chemistry | Water - chemistry | Polymers - chemistry | Dosage Forms | X-Ray Diffraction - methods | Caprolactam - chemistry | Polyvinyls - chemistry
improved dissolution rate | Raman microscopy | electrospinning | solid solution | solid dispersion | polymeric drug delivery | oral drug delivery | extrusion | nanotechnology | nanofibers | Electrospinning | Extrusion | Improved dissolution rate | Solid dispersion | Oral drug delivery | Polymeric drug delivery | Nanofibers | Solid solution | Nanotechnology | DISPERSIONS | CHEMISTRY, MEDICINAL | BEHAVIOR | AMORPHOUS STATE | PHARMACEUTICAL SYSTEMS | CHEMISTRY, MULTIDISCIPLINARY | SOLUBILITY | SPIRONOLACTONE | WATER-SOLUBLE DRUGS | ORAL BIOAVAILABILITY | PHARMACOLOGY & PHARMACY | MELT EXTRUSION | Chemistry, Pharmaceutical - methods | Calorimetry, Differential Scanning - methods | Solubility | Spironolactone - chemistry | Polyethylene Glycols - chemistry | Technology, Pharmaceutical - methods | Spectrum Analysis, Raman - methods | Drug Carriers - chemistry | Microscopy, Electron, Scanning - methods | Ethanol - chemistry | Water - chemistry | Polymers - chemistry | Dosage Forms | X-Ray Diffraction - methods | Caprolactam - chemistry | Polyvinyls - chemistry
Journal Article
1974, ISBN 0815505205, Volume no. 24., xii, 339
Book
1987, 3rd ed., ISBN 9780812110678, xii, 409
Book
2014, 2nd ed., Drugs and the pharmaceutical sciences, ISBN 9781420086355, Volume 129, xii, 385
"This book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulations, pharmaceutical...
standards | Generic drugs | Tablets | Drug Approval | Chemistry, Pharmaceutical | Solid dosage forms | Drugs, Generic
standards | Generic drugs | Tablets | Drug Approval | Chemistry, Pharmaceutical | Solid dosage forms | Drugs, Generic
Book
1981, 3d ed. --, ISBN 0812107713, viii, 408
Book
1985, 4th ed. --, ISBN 9780812109566, viii, 405
Book
2005, Drugs and the pharmaceutical sciences, ISBN 9780824754600, Volume 143, xi, 381
Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to...
Generic drugs | Solid dosage forms | Drug Design & Development
Generic drugs | Solid dosage forms | Drug Design & Development
Book
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 11/2016, Volume 108, pp. 41 - 53
Skin is a multifunctional organ with activities in protection, metabolism and regulation. Skin is in a continuous exposure to oxidizing agents and inflammogens...
Franz cells | Antiinflammatory activity | Wound healing | Skin antiaging | In vivo skin penetration | Antioxidant activity | Quercetin | In vitro skin penetration | PERCUTANEOUS PENETRATION | OXIDATIVE STRESS | HAIRLESS MOUSE SKIN | BETA-CAROTENE | IN-VITRO EVALUATION | POTENTIAL TREATMENT | PHARMACOLOGY & PHARMACY | LIPID-BASED NANOSYSTEMS | NF-KAPPA-B | Antioxidants - chemistry | Nanoparticles - chemistry | Humans | Male | Administration, Cutaneous | Wound Healing | Reactive Oxygen Species - chemistry | Swine | Water - chemistry | Quercetin - administration & dosage | Anti-Inflammatory Agents - administration & dosage | Female | Cell Line | Quercetin - chemistry | Emulsions - chemistry | Solubility | Rats | Skin Absorption | Keratinocytes - cytology | Particle Size | Animals | Anti-Inflammatory Agents - chemistry | Nanomedicine - methods | Antioxidants - administration & dosage | Mice | Nanoparticles - administration & dosage | Skin - drug effects | Antioxidants | Flavonoids | Care and treatment | Flavones | Dermatology | Bioflavonoids | Dietary supplements | Formulae, receipts, prescriptions | Physiological aspects | Dermatologic agents | Skin | Wounds and injuries
Franz cells | Antiinflammatory activity | Wound healing | Skin antiaging | In vivo skin penetration | Antioxidant activity | Quercetin | In vitro skin penetration | PERCUTANEOUS PENETRATION | OXIDATIVE STRESS | HAIRLESS MOUSE SKIN | BETA-CAROTENE | IN-VITRO EVALUATION | POTENTIAL TREATMENT | PHARMACOLOGY & PHARMACY | LIPID-BASED NANOSYSTEMS | NF-KAPPA-B | Antioxidants - chemistry | Nanoparticles - chemistry | Humans | Male | Administration, Cutaneous | Wound Healing | Reactive Oxygen Species - chemistry | Swine | Water - chemistry | Quercetin - administration & dosage | Anti-Inflammatory Agents - administration & dosage | Female | Cell Line | Quercetin - chemistry | Emulsions - chemistry | Solubility | Rats | Skin Absorption | Keratinocytes - cytology | Particle Size | Animals | Anti-Inflammatory Agents - chemistry | Nanomedicine - methods | Antioxidants - administration & dosage | Mice | Nanoparticles - administration & dosage | Skin - drug effects | Antioxidants | Flavonoids | Care and treatment | Flavones | Dermatology | Bioflavonoids | Dietary supplements | Formulae, receipts, prescriptions | Physiological aspects | Dermatologic agents | Skin | Wounds and injuries
Journal Article